Results 211 to 220 of about 29,068 (273)

Annual newsletter at M12

open access: yes
Plan and release a simple and accessible newletter to update both patients and interested parties on project aims.
openaire   +1 more source

Persistence of lung hyperinflation and small airway dysfunction in school-aged children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: results from the real-world MODUL-CF study. [PDF]

open access: yesERJ Open Res
Colin L   +25 more
europepmc   +1 more source

Exploitation of results (M12)

open access: yes
Exploitation of results – development of best practice guidelinesDelivery dates M12 & ...
openaire   +1 more source

Long-Term Effectiveness and Safety of LCIG in Romania. 3-year Results from a Prospective, Observational Study (DUOGLOBE). [PDF]

open access: yesNeuropsychiatr Dis Treat
Szasz JA   +9 more
europepmc   +1 more source

Exploitation plan M12

open access: yes
This deliverable consists of a written report that will be updated every year, reporting the exploitation plan and the strategies and activities carried out by each partner and by the consortium for best exploitation of the project outcomes.
openaire   +3 more sources

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fat-Soluble Vitamin Status in 2 to 5 Year-Old Children Using a Cystic Fibrosis-Specific Multivitamin Formulation. [PDF]

open access: yesChildren (Basel)
Munck A   +11 more
europepmc   +1 more source

Training activities - M12

open access: yes
Report to be prepared on a 12month basis describing the training activities ...
openaire   +1 more source

Home - About - Disclaimer - Privacy